Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 319,019
  • Shares Outstanding, K 18,799
  • Annual Sales, $ 19,740 K
  • Annual Income, $ 3,270 K
  • 60-Month Beta 1.31
  • Price/Sales 16.16
  • Price/Cash Flow 100.04
  • Price/Book 7.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.05
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.06 +16.40%
on 06/26/19
18.33 -4.36%
on 07/08/19
-0.07 (-0.40%)
since 06/19/19
3-Month
15.06 +16.40%
on 06/26/19
20.00 -12.35%
on 05/21/19
+1.17 (+7.15%)
since 04/18/19
52-Week
9.15 +91.58%
on 12/21/18
26.35 -33.47%
on 08/23/18
-3.59 (-17.00%)
since 07/19/18

Most Recent Stories

More News
BioLife Solutions to Acquire SAVSU Technologies

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell and gene therapies, today...

BLFS : 17.53 (+3.30%)
BioLife Solutions to Join Russell 3000® Index

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing devices for cell and...

BLFS : 17.53 (+3.30%)
BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing devices for cell and...

BLFS : 17.53 (+3.30%)
NVS : 93.56 (-0.74%)
Precision Therapeutics' Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant

Precision Therapeutics Inc., (Nasdaq: AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that its Helomics...

AIPT : 0.64 (+6.67%)
MRK : 81.39 (-1.57%)
BLFS : 17.53 (+3.30%)
CELGZ : 0.47 (-5.98%)
BioLife Solutions Announces First Quarter 2019 Financial Results

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell...

BLFS : 17.53 (+3.30%)
BioLife Solutions to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media for cell and gene therapies, ("BioLife" or the "Company"), today...

BLFS : 17.53 (+3.30%)
Market Trends Toward New Normal in Continental Resources, Merit Medical, Global Medical REIT, Cardinal Health, BioLife Solutions, and ChannelAdvisor -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Continental Resources, Inc....

MMSI : 55.02 (-1.36%)
CLR : 36.26 (-0.55%)
GMRE : 10.32 (-2.27%)
BLFS : 17.53 (+3.30%)
CAH : 44.99 (-0.44%)
ECOM : 9.16 (-2.14%)
BioLife Solutions Completes Acquisition of Astero Bio

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife") today announced that it has closed the previously announced transaction for the acquisition of Astero Bio Corporation ("Astero"), an innovator in the...

BLFS : 17.53 (+3.30%)
BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary cell and tissue hypothermic storage and cryopreservation freeze media, today reported...

BLFS : 17.53 (+3.30%)
BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio

BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife") today announced that it has entered into an agreement to acquire Astero Bio Corporation ("Astero"), a privately-held innovator in the design, development...

BLFS : 17.53 (+3.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade BLFS with:

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

2nd Resistance Point 18.14
1st Resistance Point 17.83
Last Price 17.53
1st Support Level 17.03
2nd Support Level 16.54

See More

52-Week High 26.35
Fibonacci 61.8% 19.78
Fibonacci 50% 17.75
Last Price 17.53
Fibonacci 38.2% 15.72
52-Week Low 9.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar